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ABSTRACT
￿
We have obtained evidence by autoradiography and immunocytochemistry that
mature secretory granules of the pancreatic B-cell gain access to a lysosomal compartment
(multigranular or crinophagic bodies) where the secretory granule content is degraded .
Whereas the mature secretory granule content shows both insulin and C-peptide (proinsulin)
immunoreactivities, in crinophagic bodies only insulin, but not C-peptide, immunoreactivity
was detectable. The absence of C-peptide (proinsulin) immunoreactivity in multigranular
bodies, i.e., in early morphological stages of lysosomal digestion, was compatible with the
ready access and breakdown of C-peptide and/or proinsulin by lysosomal degrading enzymes,
while the insulin crystallized in secretory granule cores remained relatively protected. How-
ever, in the final stage of lysosomal digestion, i .e., in residual bodies where the secretory
granule core material is no longer present, insulin immunoreactivity became undetectable.
Lysosomal digestion thus appears to be a normal pathway for insulin degradation in the
pancreatic B-cell.
The pancreatic B-cell shares with other polypeptide-secreting
cells the ability to store its secretory products within cytoplas-
mic granules available for release by exocytosis (1, 2). How-
ever, the totality of insulin manufactured is not destined to
be secreted, since it has been shown that the B-cell can degrade
a significant portion of its own secretory product (3, 4). One
commonly assumed mechanism of intracellular degradation
ofinsulin by the B-cell is the fusion ofsecretory granules with
primary lysosomes (5, 6), a mechanism called granulolysis or
crinophagy and initially described in the mammotroph cells
ofthe anterior pituitary (7) and pancreatic A-cells (8). In the
B-cell, morphological evidence for crinophagy consists of
cytoplasmic organelles (secondary lysosomes) that present a
very variable morphology but usually contain dense masses
resembling a-secretory granule cores. The lysosomal nature
of these structures (also called crinophagic or multigranular
bodies) is evidenced by their content in marker lysosomal
enzymes such as acid phosphatase or arylsulfatase (9), but
whether the content ofthe granule core-like material is related
to insulin polypeptides has not been ascertained. For this
purpose, we have followed, by electron microscopic autora-
diography, the labeling of the multigranular bodies in pulse-
chase experiment with tritiated leucine, and determined their
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immunoreactive content using anti-insulin and anti-C-pep-
tide antisera revealed by the protein A-gold method.
MATERIALS AND METHODS
Rat islets ofLangerhans in sections ofpancreatic tissue or isolated by collagen-
ase digestion (10) were studied throughout. The material examined originated
from the tissue store of the laboratory. All blocks were from five untreated
normal rats, the pancreas (or isolated islets) of which were fixed in 2.5%
glutaraldehyde alone or with a mixture of 1 .25% glutaraldehyde, I% paraform-
aldehyde, and 0.02% trinitrocresol (11), then postfixed in osmium tetroxide
and embedded in Epon or Epon-Araldite. Beside Epon-embedded material,
isolated islets embedded at low temperature in Lowicryl resin (12) or lightly-
fixed (1% glutaraldehyde alone) tissue processed by ultracryotomy (13) were
studied.
Autoradiography:
￿
The pulse-chase labeling of isolated islets with trit-
iated leucine was carried out as described previously (14). In this case, batches
of freshly isolated islets from three normal untreated rats were maintained in
Dulbecco's modified Eagle medium (Gibco Laboratories, Grand Island, NY)
containing 10% fetal calf serum and 8.3 mM glucose for 72 h (equilibration
period)at 37°C. This 3-d equilibration periodallows full recovery from possible
damage caused by the isolation procedure. Islets were then transferred in 0.5
ml of Krebs-Ringerbicarbonate-HEPES buffer at 37°C and labeled for 30 min
with 1'Hlleucine (I mCi/ml, 62 Ci/mmol). At the end of the labeling period,
the isolated islets were returned to the Dulbecco's modified Eagle medium at
37°C and further incubated for 3- and 24-h chase periods. Prior to fixation, at
the end of the labeling period or following the chase, aliquots of islets were
washed in Krebs-Ringer bicarbonate-HEPES buffer and fixed with 2.5% glu-
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in Epon. Thin sections were prepared and autoradiographed with the loop
method of Caro and van Tubergen (15) using Ilford 1.4 emulsion. Exposure
time was -6 wk. Following development of the emulsion, sections were
photographedsystematicallyto record autoradiographicgrains.The distribution
and frequency of the grains over the various intracellular compartments was
evaluated quantitatively by the probability circle method (16) coupled to the
morphometry ofthe cell compartments(17) in six different islets for each time
point.
Immunocytochemistry:
￿
Thin sections of the five normal untreated
rat islets variously processed and embedded as described above (this material
was distinct from that prepared forautoradiography) were picked up on nickel
support grids and prepared forultrastructural immunocytochemistry by oxidiz-
ing (when applicable) excess osmium tetroxide with H202 (18) or NaI04 (19).
Deosmified sections (or nonosmified Lowicryl or ultracryotomy sections) were
incubatedovernight at 4°C with anti-insulin (lot no. 573; agiftfrom Dr. Wright,
Indiana University, Indianapolis) or withanti-C-peptide (lot no. R-901) antisera
at various dilutions (1:400-1 :10,000 for insulin; 1 :500-1:2,000 for C-peptide.
The dilution ofthe antisera needed to keep the tissular background as low as
possbile was empirically established for each processing protocol.). Following
several washes in distilled water, the sections were further incubated with the
protein A-gold solution (20), rinsed in distilled water, and stained with uranyl
acetate and lead citrate. Immunolabeled sections were systematically photo-
graphed in the electron microscope and the distribution of gold particles
(revealing antigenic binding sites) was visually assessed. In addition, a quanti-
tative evaluation ofthe immunolabeling was carried out in samples of islets
fixed and embedded according to different procedures(Table I). This was done
by recording in each case the number of gold particles per unit area (square
microns) of selected cytoplasmic compartments using an electronic pen con-
nected to a microprocessor. The system allowed the measuring the number of
single events (i.e., gold particles)together withthe surface ofthe compartments
in which they occurred. Specificity of the immunolabeling was assessed by
incubation of sections with antisera previously adsorbed with their respective
antigens. No specific labeling (i.e., above cellular background) was obtained in
these conditions.
Cytochemistry:
￿
The acid phosphatase and arylsulfatase activities of
multigranular bodies were demonstrated in 40-km sections (cut with a tissue
chopper) ofpellets ofglutaraldehyde-fixed,isolated islets ofLangerhans accord-
ing to the methods of Gomori (21), and Bentfelt-Barker and Bainton (22),
respectively. Osmium tetroxide postfixation and Epon embedding were carried
out after the completion ofthe cytochemical reactions.
RESULTS
The intracellular compartments of the pancreatic B-cell
thought to be involved in lysosomal degradation of insulin
were the following: (a) individual noncoated secretory gran-
Anti-insulin
Anti-C-peptide
ules (Fig. 1 a) considered as the end stage ofgranule matura-
tion (2, 23, 24); (b) lysosomes identified on both structural
(25) and cytochemical (acid phosphatase and arylsulfatase
activity) criteria (9). Lysosomes could be further subdivided
into (a) multivesicular bodies assumed to be representative of
primary lysosomes before they interact with an intra- or
extracellular compartment (7, 26); (b) dense bodies with het-
erogeneous, unclassifiable content often consisting of lipid
"droplets" and/or "myelin" figures (Fig. 4c); these are also
called residual bodies and represent the end stage oflysosomal
digestion; and (c) crinophagic or multigranular bodies, i.e.,
membrane sacs of various shapes and sizescontaining one or
several masses resembling secretory granule cores (Figs. 1 a,
3, a and b). Multigranular bodies are considered secondary
lysosomes, as well as multivesicular bodies when they contain
granule core-like material (Fig. 4, a and b). Crinophagic bodies
show acid phosphatase and arylsulfatase activity (Fig. 1, b and
c). Due to the morphological similarity between the content
ofmultigranular bodies and the secretory granule cores, these
bodies (and the multivesicular bodies when they contain
granule core-like material; see Fig. 4, a and b) are believed to
be the sites of lysosomal degradation of insulin. The pattern
of autoradiographic labeling of secretory granules in B-cells
of isolated islets after a 30-min pulse of tritiated leucine
followed by 3 and 24 h of chase is shown in Fig. 2 a, that of
multigranular bodies in Fig. 2b. From 0.5 to 3 h, the radio-
activity increased significantly in the secretory granule com-
partment and slowly decreased from 3 to 24 h. The radioac-
tivity in the multigranular body compartment was low up to
3 h whereas it increased significantly from 3 to 24 h. This
pattern, together with the morphological similarity noted
above between the cores ofsecretorygranules and those visible
in crinophagic bodies, suggested a process offunneling of part
of radioactive peptides from the secretory granule compart-
ment into the multigranular body compartment. In the ex-
periments analyzed, the process appeared slow and not to
involve newly formed granules since the multigranular bodies
were not significantly labeled until 3 h afterthe pulse. During
the period of time studied, the multivesicular body compart-
Quantitative evaluation of the number of gold particles over secretory granules and multigranular bodies of the B-cell following incubation with anti-insulin
and anti-C-peptide antisera revealed by the protein A-gold technique. Data are means t SEM. Values in parenthesis are the number of pictures evaluated in
each condition. None of the values of C-peptide immunolabeling in multigranular bodies is significantly different from cellular background. Processing
protocol: A, glutaraldehyde-paraformaldehyde-trinitrocresol-osmium fixation, Epon-Araldite embedding (one rat, three islets in situ). Antibody dilution: insulin
= 1 :400; C-peptide = 1:1,000; B, glutaraldehyde-osmium fixation, Epon embedding (one rat, three isolated islets). Antibody dilution: insulin = 1 :400; C-
peptide = 1 :500; C, glutaraldehyde alone (1%), low temperature embedding in Lowicryl resin (pool of three rats, nine islets). Antibody dilution: insulin =
1 :10,000; C-peptide = 1:2,000.
These comprise multivesicular bodies with granule core-like material.
s Values determined over the granule core-like material alone.
s Values determined over the entire multigranular body.
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TABLE I
Number of Gold Particles
protocol Secretory granules Multigranular bodies* Background
A 185.7 ± 14.1 (39) 166.3 ± 11 .8 (37)*
101 .6 ± 8.2 (37)s
1 .44 ± 0.23 (8)
B 61 .3 ± 5.6 (17) 51 .5±8.8 (18);
27.7 ± 4.9 (20)s
0.54 ± 0.10 (5)
C 124.6 ± 6.0 (49) 73.8 ± 7.0 (25) 0.40±0.19(19)
A 188.6 ± 9.2 (33) 10.4 ± 2 .5 (33);
8.5 ± 1 .5 (35)s
4.14 ± 0.69 (8)
B 34.1 ± 4.0 (19) 2.4±1 .31 (16);
1 .7 ± 0.80 (17)s
0.84 ± 0.29 (8)
C 120.0 ± 4.2 (51) 4.0 ± 1 .28 (27) 1 .08 ± 0.34 (18)FIGURE 1
￿
(a) Thin section of part of a B-cell cytoplasm illustrating the two compartments thought to be involved in lysosomal
digestion of insulin polypeptides . These comprise secretory granules (SG) and multigranular (crinophagic) bodies (MGB) . Note
the morphological similarity between the secretory granule core and the dense, round masses within the multigranular body .
Glutaraldehyde-osmium fixation ; Epon embedding . (b) Field of a B-cell cytoplasm showing secretory granules (SG) and a
multigranular (crinophagic) body (MGB) after cytochemical demonstration of acid phosphatase. The dense reaction product filling
the multigranular body outlines the secretory granule core-like material . As described previously, a positive acid phosphatase
reaction is present in the halo of some granules (32) . Glutaraldehyde fixation, osmium postfixation (following cytochemistry) ;
Epon embedding . (c) Field of a B-cell cytoplasm as in a but following cytochemical demonstration of arylsulfatase . The three
multigranular bodies (MGB) present in the field are cytochemically labeled, but unlike the situation with acid phosphatase, none
of the secretory granules is reactive . The incubation in the cytochemical medium for arylsulfatase induced some loss of contrast
in the secretory granule cores . Glutaraldehyde fixation, osmium postfixation (followingcytochemistry) ; Epon embedding . x 57,000
(a) ; x 51,000 (b) ; x 27,000 (c) .
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FIGURE 2 Quantitative
evaluation of the autoradi-
ographic reaction in three
compartments of the B-cell
thought to be involved in
lysosomal degradation of
insulin. The radioactivity in
each compartment is ex-
pressed as the specific ra-
diation label density (Rvi')
which represents the num-
ber of autoradiographic
grains per unit volume of
the compartment (16, 17).
The experiment involved a
pulse of 30 min (0.5 h) fol-
lowed by chase periods of
3 and 24 h. The first time
point evaluated is at the
end of the 0.5-h pulse. The
asterisks at 3 h indicate in
a, a value significantly dif-
ferent (p < 0.05) from that
at 30 min, and in b, from
that at 24 h. Each time
point is the result of the
evaluation of six different
isolated islets and repre-
sents a mean t SEM (ver-
tical bar). Glutaraldehyde-
osmium fixation. Epon
embedding. The three
curves derive from the
analysis of a total number
of 1,778 autoradiographic
grains.
ment without granule-core like material, i.e., representative
of primary lysosomes before interaction with endogenous or
exogenous material (7, 26), showed a pattern of autoradi-
ographic labeling that was the inverse of that of crinophagic
bodies, namely a high levelofradioactivity at 30 min, decreas-
ing markedly and significantly by 3 h, and remaining low up
to 24 h (data not shown). This labeling was assumed to be
due to the radioactivity incorporated into lysosomal enzymes.
The pattern of autoradiographic labeling of residual bodies is
shown in Fig. 2 c. It revealed a constant level of radioactivity
over the period of time studied.
The qualitative assessment of immunocytochemical stain-
ing after application of insulin or C-peptide antisera showed
the following constant pattern: all secretory granules appeared
labeled with both anti-insulin and anti-C-peptide antisera (Fig
3, a and b). Multigranularbodies showedby contrast a marked
immunoreactivity towards the anti-insulin antiserum (Fig.
3 a), but virtually no labeling with the anti-C-peptide antise-
rum (Fig. 3b). Multivesicular bodies containing granule core-
like material (Fig. 4, a and b) were also different in immu-
noreactivity as multigranular bodies. The denseresidual bod-
ies without identifiable granule core-like material (Fig. 4c)
presented, by contrast, no immunolabeling either with anti-
insulin or with anti C-peptide antisera. The tissue embedded
at low temperature in Lowicryl resin and that lightly fixed
with glutaraldehyde and submitted to ultracryotomy showed
a pattern of labeling comparable with that described above.
The results of the quantitative evaluation of the protein A-
gold immunolabeling in samples of islets fixed and embedded
following various proceduresis shown in Table I. Irrespective
ofthe processing protocol used, the quantitative data revealed
a comparable difference (although the values varied in abso-
lute terms} in the immunolabeling of secretory granules and
crinophagic bodies when insulin and C-peptide antisera were
used.
DISCUSSION
The present data offerevidence that, in the pancreatic B-cell,
insulin polypeptides are introduced into a lysosomal com-
partment; this process may represent, at least in part, the
substratumfor intracellular insulin degradation demonstrated
in B-cells by biochemical experiments (3, 4). Lysosomal deg-
radation of secretory polypeptides would thus appear to be a
normal component of the insulin cycle.' This conclusion was
based upon autoradiography, which showed the kinetics of
the migration of tritiated polypeptides between intracellular
compartments, and immunocytochemistry, which allowed
the identification of the content of these compartments. The
difference in the pattern ofradioactive labeling of multigran-
ular bodies and residual bodies is particularly interesting with
respect to the hypothesis that the former are a site of insulin
degradation. Multigranular bodies would represent an early
stage of the degradation process at which the characteristic
granule core-like structures are still detectable together with
their associated radioactivity. That autoradiographic grains of
multigranular bodies reveal insulin polypeptides rather than
lysosomal enzymes themselves is suggested by the time course
of the labeling. The increase in multigranular body labeling
occurs at a time (between 3 h and 24 h) when the radioactive
content of multivesicular bodies (representative of primary
lysosomes) is already low; this increase would result from the
uptake of additional radioactive material, most likely insulin
polypeptides, by multigranular bodies. In residual bodies,
recognizable structures that resemble granule cores are no
longer present and it can be assumed that radiolabeled frag-
ments originating from insulin breakdown have diffused
across the lysosomal membrane to reach the cytosol (26),
keeping therefore a constant low level of radioactivity in the
residual body itself. This hypothesis may be confirmed by the
immunocytochemical data ofthe present investigation show-
ing that multigranularbodies contain insulin immunoreactive
sites, whereas residual bodies do not. The finding that crino-
phagic bodies, unlike secretory granules from which they are
assumed to derive, were not labeled at significant levels by C-
peptide antiserum can be interpreted as follows: in mature,
dense-core secretory granules, insulin may form crystals in-
volving zinc ions (27) and probably excluding C-peptide (28,
29). Upon fusion ofone or several granue(s) with a primary
lysosome to form a multigranular body, C-peptide is thus
likely to be more easily accessible and digestible by lysosomal
enzymes than the compact and relatively insoluble (27) in-
sulin crystals. This was evidenced by the link between the
presence of insulin immunoreactivity and the granule core
'The material analyzed was not intended to assess the magnitude of
this process, nor whether it can be experimentally modulated by the
stimulation ofthe &cell secretion.
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(a) Thin section of a pancreatic B-cell immunostained with the protein A gold technique for the demonstration of
insulin . Two multigranular (crinophagic) bodies (MGB) present in this field show numerous gold particles over the secretory
granule core-like material . The secretory granules (SG) either with dense or pale core are similarly labeled . The quantitative
evaluation of the immunoreaction over multigranular bodies and secretory granules is shown in Table I . (b) Thin section
comparable to that shown in a but immunostained with an anti-C-peptide antiserum . Although this antiserum marks the pale and
dense-core secretory granules (SG) as the anti-insulin antiserum, the two multigranular bodies (MGB) present in this field appear
virtually not labeled . The quantitative evaluation of labeling is shown in Table I . (a and b) Glutaraldehyde-paraformaldehyde-
trinitrocresol-osmium fixation, Epon-Araldite embedding . x 38,000 .
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Fields of B-cell cytoplasm stained with either anti-insulin
(a, c) or anti-C-peptide (b) antisera revealed by the protein A gold
technique ; a illustrates a multivesicular body (MVB) with its char-
acteristic coated membrane segments and that contains granule
core-like material immunostained with anti-insulin antiserum . b
shows another example of a multivesicular body (MVB) containing
a granule core, but immunostained with anti-C-peptide antiserum .
No significant labeling is detectable as compared with the neigh-
boring secretory granule . Multivesicular bodies with granule core-
like material are considered secondary lysosomes and were evalu-
ated together with multigranular bodies in Table I . c shows a residual
body (RB) where secretory granule core structure(s) are no longer
present . At this stage, assumed to represent the terminal stage of
digestion, insulin immunoreactivity is absent whereas it remains
detectable in a neighboring multigranular body (MGB). Sections in
a and b were immunostained with small size gold particles produced
with tannic acid (33) . Glutaraldehyde-paraformaldehyde-trinitro-
cresol-osmium fixation; Epon-Araldite embedding. x 76,000 (a and
b) ; x 48,000 (c).
appearance, both of which are lost at the residual body stage
when degradation is assumed to have been completed, accom-
panied by granule core dissolution . It must be emphasized
that the quantitative data presented do not allow the estima-
tion of the actual immunoreactive polypeptide content of
secretory granules and/or multigranular bodies, since the ratio
between the number of antigenic sites and the number of
protein A-gold particles is unknown for our antisera in any
of the fixation/embedding protocols . In addition, the C-pep-
tide antiserum recognizes both the C-peptide region of proin-
sulinand the C-peptide molecule itselfreleased upon cleavage
ofproinsulin into insulin . In this respect, C-peptide antiserum
is a marker ofproinsulin as well as ofC-peptide (30). Likewise,
the anti-insulin antiserum reacts primarily with the insulin
molecule, but a certain degree of cross-reactivity with proin-
sulin is also known to occur . These various specificities em-
phasize the relative significance of the numbers of gold par-
ticles measured in the different compartments.A last caution-
ary note concerns the fixation ofthe C-peptide molecule: due
to the relative small size and limitednumber of sites available
for cross-linking by glutaraldehyde, C-peptide may not be
completely retained during tissue processing . If such a wash-
out occurs, the observed C-peptide immunoreactivity would
thus represent proinsulin which is also present in secretory
granules (29) and/or intermediates, rather than C-peptide
itself . Although the presence of distinct C-peptide immuno-
reactivity in ultracryotomy sections that have not undergone
dehydration and embedding (i.e., where washing out of poorly
fixed molecules should be greatly reduced) speaks in favor of
C-peptide being retained in our experimental conditions, the
data that shows sequential disappearance ofsecretory granule
immunoreactive content upon encounter with lysosomes re-
main valid, irrespective of whether C-peptide, proinsulin, or
both were labeled.
In summary, we have presented autoradiographic and im-
munocytochemical evidence that secretory granules of the
pancreatic B-cell gain access to a lysosomal compartment
where they appear to be morphologically degraded, together
with their insulin and C-peptide immunoreactivites. Insulin
immunoreactivity disappears at a later morphological stage
oflysosomal digestion than C-peptide immunoreactivity, sug-
gesting a greater resistance of the insulin crystal to hydrolytic
digestion as compared with C-peptide and/or proinsulin . Ly-
sosomal action would thus account, at least in part, for the
normal pattern ofinsulin degradation in the B-cell . This does
not exclude, however, other pathways for degradation as
suggested by the presence, in pancreatic islets, of apparently
nonlysosomal insulin degrading enzymes (31) .
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